Back
Haemonetics Vs. NovoCure Industry Stock Comparison
Buy
68
HAE
Haemonetics
Last Price:
82.24
Seasonality Move:
1.23%
Buy
61
NVCR
NovoCure
Last Price:
31.80
Seasonality Move:
-5.24%
Buy
68
Haemonetics (HAE)
is a Buy
Is Haemonetics a Buy, Sell or Hold?
- The current Haemonetics [HAE] share price is $82.25. The Score for HAE is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- HAE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $31.75. The Score for NVCR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HAE Stock Price Chart
What is Haemonetics's stock price today?
-
The Haemonetics share price today is $82.25
The current trend is moderately bearish and HAE is experiencing buying pressure, which is a positive indicator for future bullish movement.
HAE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 46.65 | Sell |
| Chaikin Money Flow: | 296695 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.56 - 89.58) | Sell |
| Bollinger Bands (100): | (73.56 - 85.72) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.81 | Buy |
| Relative Strength Index (14 RSI): | 69.18 | Buy |
| Chaikin Money Flow: | -1161078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.76 - 29.3) | Buy |
| Bollinger Bands (100): | (14.61 - 23.11) | Buy |
HAE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.22 | Buy |
| 20-day SMA: | 84.76 | Sell |
| 50-day SMA: | 80.99 | Buy |
| 200-day SMA: | 82.84 | Sell |
| 8-day EMA: | 82.77 | Sell |
| 20-day EMA: | 83.59 | Sell |
| 50-day EMA: | 82.22 | Buy |
| 200-day EMA: | 82.04 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.91 | Buy |
| 20-day SMA: | 24.46 | Buy |
| 50-day SMA: | 19.68 | Buy |
| 200-day SMA: | 17.98 | Buy |
| 8-day EMA: | 30.02 | Buy |
| 20-day EMA: | 26.05 | Buy |
| 50-day EMA: | 21.79 | Buy |
| 200-day EMA: | 20 | Buy |
Haemonetics Earnings Growth & HAE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.63 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
Haemonetics Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||